APA (7th ed.) Citation

Sharma, S., Group, R. 2. S. I., Anandkumar, M. B., Jain, S., Murthy, H., Murlidhar, N. S., . . . Sahu, A. K. (2020). A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion. Ophthalmology & Therapy, 9(3), 625. https://doi.org/10.1007/s40123-020-00277-3

Chicago Style (17th ed.) Citation

Sharma, Shashikant, et al. "A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion." Ophthalmology & Therapy 9, no. 3 (2020): 625. https://doi.org/10.1007/s40123-020-00277-3.

MLA (9th ed.) Citation

Sharma, Shashikant, et al. "A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion." Ophthalmology & Therapy, vol. 9, no. 3, 2020, p. 625, https://doi.org/10.1007/s40123-020-00277-3.